New advances in the diagnosis and treatment of POEMS syndrome

British Journal of Haematology

Volumn 161, Issue 3, 2013, Pages 303-315

  Li, Jian ^a   Zhou, Dao bin ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Autologous peripheral blood stem cell transplantation; Lenalidomide; Melphalan; POEMS syndrome; Vascular endothelial growth factor

Indexed keywords

BEVACIZUMAB; BORTEZOMIB; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DEXAMETHASONE; DIURETIC AGENT; FUROSEMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; LENALIDOMIDE; M PROTEIN; MELPHALAN; PREDNISONE; SPIRONOLACTONE; THALIDOMIDE; THYROXINE; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; ADRENAL INSUFFICIENCY; AMYLOIDOSIS; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; ASCITES; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BONE SCINTISCANNING; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; EARLY DIAGNOSIS; EDEMA; ELECTROPHORESIS; EXERCISE; GRAFT FAILURE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MONOCLONAL IMMUNOGLOBULINEMIA; MORBIDITY; MORTALITY; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; PATHOGENESIS; PHYSIOTHERAPY; PLEURA EFFUSION; POEMS SYNDROME; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PULMONARY HYPERTENSION; REMISSION; STEM CELL MOBILIZATION; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL, HUMANIZED; BORONIC ACIDS; CHROMOSOME ABERRATIONS; COMBINED MODALITY THERAPY; DEXAMETHASONE; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; GENES, IMMUNOGLOBULIN; GIANT LYMPH NODE HYPERPLASIA; HUMANS; HYPERTENSION, PULMONARY; MELPHALAN; OSTEOSCLEROSIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PLASMA CELLS; POEMS SYNDROME; PROGNOSIS; PYRAZINES; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT; THALIDOMIDE; TRANSPLANTATION, AUTOLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876174288     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12236     Document Type: Article

References (97)

1. Abe, D., Nakaseko, C., Takeuchi, M., Tanaka, H., Ohwada, C., Sakaida, E., Takeda, Y., Oda, K., Ozawa, S., Shimizu, N., Masuda, S., Cho, R., Nishimura, M., Misawa, S., Kuwabara, S. & Saito, Y. (2008) Restrictive usage of monoclonal immunoglobulin lambda light chain germline in POEMS syndrome. Blood, 112, 836-839.
2. Alberti, M.A., Martinez-Yelamos, S., Fernandez, A., Vidaller, A., Narvaez, J.A., Cano, L.M., Gamez, C. & Martinez-Matos, J.A. (2010) 18F-FDG PET/CT in the evaluation of POEMS syndrome. European Journal of Radiology, 76, 180-182.
3. Allam, J.S., Kennedy, C.C., Aksamit, T.R. & Dispenzieri, A. (2008) Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137 patients. Chest, 133, 969-974.
4. Aravamudan, B., Tong, C., Lacy, M.Q., Hayman, S.R., Buadi, F., Gertz, M.A., Kumar, S. & Dispenzieri, A. (2008) Immunoglobulin variable light chain restriction, cytokine expression and plasma cell-stromal cell interactions in POEMS syndrome patients. Blood, 112, abstract 2744.
5. Arimura, K. (2012) Early recognition of POEMS syndrome: what is the role of clinical neurophysiology. Journal of Neurology Neurosurgery & Psychiatry, 83, 474.
6. Badros, A., Porter, N. & Zimrin, A. (2005) Bevacizumab therapy for POEMS syndrome. Blood, 106, 1135.
7. Bardwick, P.A., Zvaifler, N.J., Gill, G.N., Newman, D., Greenway, D.L. & Resnick, D.L. (1980) Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature. Medicine, 59, 311-322.
8. Briani, C., Fabrizi, G.M., Ruggero, S., Torre, C.D., Ferrarini, M., Campagnolo, M., Cavallaro, T., Ferrari, S., Scarlato, M., Taioli, F. & Adami, F. (2011) Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias. Muscle and Nerve, 43, 164-167.
9. Briani, C., Manara, R., Lessi, F., Citton, V., Zambello, R. & Adami, F. (2012) Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy. American Journal of Hematology, 87, 539-541.
10. Bryce, A.H., Ketterling, R.P., Gertz, M.A., Lacy, M., Knudson, R.A., Kumar, S., Kyle, R.A., Fonseca, R., Greipp, P.R., Lust, J.A., Rajkumar, V.S., Hayman, S.R., Buadi, F., Russell, S.J., Zeldenrust, S.R. & Dispenzieri, A. (2008) A novel report of cig-FISH and cytogenetics in POEMS syndrome. American Journal of Hematology, 83, 840-841.
11. Buxhofer-Ausch, V., Gisslinger, B., Stangl, G., Rauschka, H. & Gisslinger, H. (2012) Successful treatment sequence incorporating bevacizumab for therapy of polyneuropathy in two patients with POEMS syndrome. Leukemia Research, 36, e98-e100.
12. Chan, P.T., Lee, K.C., Chong, L.Y., Lo, K.K. & Cheung, Y.F. (2006) Glomeruloid haemangioma with cerebriform morphology in a patient with POEMS syndrome. Clinical and Experimental Dermatology, 31, 775-777.
13. Chung, W.K., Lee, D.W., Yang, J.H., Lee, M.W., Choi, J.H. & Moon, K.C. (2009) Glomeruloid hemangioma as a very early presenting sign of POEMS syndrome. Journal of Cutaneous Pathology, 36, 1126-1128.
14. Cook, G., Garderet, L., Biezen, A.V., Henseler, A., Leblond, V., Rovira, M., Bordessoule, D., Leone, G., Ossenkoppele, G.J., Byrne, J., Cook, M., Caballero, D., Witte, T.M. & Morris, C.T. (2011) The role of high dose chemotherapy and autologous stem cell transplantation (ASCT) in patients with POEMS syndrome: a retrospective study of the MM subcommittee of the chronic leukemia working party of the EBMT. Blood (ASH Annual Meeting Abstracts), 118, abstract 4115.
15. Cui, R.T., Huang, X.S., Shi, Q., Tian, C.L., Liu, J.X. & Pu, C.Q. (2011) POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes) syndrome in China. Internal Medicine Journal, 41, 481-485.
16. Dao, L.N., Hanson, C.A., Dispenzieri, A., Morice, W.G., Kurtin, P.J. & Hoyer, J.D. (2011) Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid, and myeloid findings in 87 patients. Blood, 117, 6438-6444.
17. Dietrich, P.Y. & Duchosal, M.A. (2008) Bevacizumab therapy before autologous stem-cell transplantation for POEMS syndrome. Annals of Oncology, 19, 595.
18. Dispenzieri, A. (2007) POEMS syndrome. Blood Review, 21, 285-299.
19. Dispenzieri, A. (2012a) POEMS syndrome: update on diagnosis, risk-stratification, and management. American Journal of Hematology, 87, 804-814.
20. Dispenzieri, A. (2012b) How I treat POEMS syndrome. Blood, 119, 5650-5658.
21. Dispenzieri, A., Kyle, R.A., Lacy, M.Q., Rajkumar, S.V., Therneau, T.M., Larson, D.R., Greipp, P.R., Witzig, T.E., Basu, R., Suarez, G.A., Fonseca, R., Lust, J.A. & Gertz, M.A. (2003) POEMS syndrome: definitions and long-term outcome. Blood, 101, 2496-2506.
22. Dispenzieri, A., Moreno-Aspitia, A., Suarez, G.A., Lacy, M.Q., Colon-Otero, G., Tefferi, A., Litzow, M.R., Roy, V., Hogan, W.J., Kyle, R.A. & Gertz, M.A. (2004) Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature. Blood, 104, 3400-3407.
23. Dispenzieri, A., Klein, C.J. & Mauermann, M.L. (2007) Lenalidomide therapy in a patient with POEMS syndrome. Blood, 110, 1075-1076.
24. Dispenzieri, A., Lacy, M.Q., Hayman, S.R., Kumar, S.K., Buadi, F., Dingli, D., Litzow, M.R., Gastineau, D.A., Inwards, D.J., Elliott, M.A., Micallef, I.N., Ansell, S.M., Hogan, W.J., Porrata, L.F., Johnston, P.A., Afessa, B., Bryce, A., Kyle, R.A. & Gertz, M.A. (2008) Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. European Journal of Haematology, 80, 397-406.
25. Dispenzieri, A., Armitage, J.O., Loe, M.J., Geyer, S.M., Allred, J., Camoriano, J.K., Menke, D.M., Weisenburger, D.D., Ristow, K., Dogan, A. & Habermann, T.M. (2012) The clinical spectrum of Castleman's disease. American Journal of Hematology, 87, 997-1002.
26. D'Souza, A., Hayman, S.R., Buadi, F., Mauermann, M., Lacy, M.Q., Gertz, M.A., Kyle, R.A., Kumar, S., Greipp, P.R., Lust, J.A., Russell, S.J., Zeldenrust, S., Dingli, D., Witzig, T.E., Rajkumar, S.V. & Dispenzieri, A. (2011) The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome. Blood, 118, 4663-4665.
27. D'Souza, A., Lacy, M., Gertz, M., Kumar, S., Buadi, F., Hayman, S., Dingli, D., Zeldenrust, S., Kyle, R., Ansell, S., Inwards, D., Johnston, P., Micallef, I., Porrata, L., Litzow, M., Gastineau, D., Hogan, W. & Dispenzieri, A. (2012) Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience. Blood, 120, 56-62.
28. Duan, M.H., Zhou, D.B., Jiao, L., Zhang, W., Zhu, T.N., Li, J. & Shen, T. (2010) Preliminary study of autologous peripheral blood stem cell transplantation in patients with POEMSsyndrome. Zhonghua Xue Ye Xue Za Zhi, 31, 744-747.
29. Dupont, S.A., Dispenzieri, A., Mauermann, M.L., Rabinstein, A.A. & Brown, R.D. Jr. (2009) Cerebral infarction in POEMS syndrome: incidence, risk factors, and imaging characteristics. Neurology, 73, 1308-1312.
30. Dyck, P.J., Engelstad, J. & Dispenzieri, A. (2006) Vascular endothelial growth factor and POEMS. Neurology, 66, 10-12.
31. Econimo, L., Jeannin, G., Biasi, L., Mazzola, G., Mendeni, M., Presteni, K. & Gregorini, G. (2011) Serum vascular endothelial growth factor (VEGF) in the differential diagnosis of amyloid neuropathy and POEMS syndrome. Amyloid, 18(Suppl 1), 101-103.
32. Ferran, M. & Gimenez-Arnau, A.M. (2006) Multiple eruptive angiomatous lesions in a patient with multiple myeloma. Glomeruloid hemangiomas associated with POEMS syndrome. Archives of Dermatology, 142, 1501-1506.
33. Gertz, M.A., Comenzo, R., Falk, R.H., Fermand, J.P., Hazenberg, B.P., Hawkins, P.N., Merlini, G., Moreau, P., Ronco, P., Sanchorawala, V., Sezer, O., Solomon, A. & Grateau, G. (2005) Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. American Journal of Hematology, 79, 319-328.
34. Gherardi, R.K., Belec, L., Fromont, G., Divine, M., Malapert, D., Gaulard, P. & Degos, J.D. (1994) Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome. Blood, 83, 2587-2593.
35. Gherardi, R.K., Belec, L., Soubrier, M., Malapert, D., Zuber, M., Viard, J.P., Intrator, L., Degos, J.D. & Authier, F.J. (1996) Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood, 87, 1458-1465.
36. Goto, H., Nishio, M., Kumano, K., Fujimoto, K., Yamaguchi, K. & Koike, T. (2008) Discrepancy between disease activity and levels of vascular endothelial growth factor in a patient with POEMS syndrome successfully treated with autologous stem-cell transplantation. Bone Marrow Transplantation, 42, 627-629.
37. Graham, R.C. & Hughes, R.A. (2006) Modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. Journal of Neurology Neurosurgery & Psychiatry, 77, 973-976.
38. Hashiguchi, T., Arimura, K., Matsumuro, K., Otsuka, R., Watanabe, O., Jonosono, M., Maruyama, Y., Maruyama, I. & Osame, M. (2000) Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle and Nerve, 23, 1051-1056.
39. Hogan, W.J., Lacy, M.Q., Wiseman, G.A., Fealey, R.D., Dispenzieri, A. & Gertz, M.A. (2001) Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantation. Bone Marrow Transplantation, 28, 305-309.
40. Inoue, D., Kato, A., Tabata, S., Kitai, T., Takiuchi, Y., Kimura, T., Shimoji, S., Mori, M., Nagai, Y., Togami, K., Matsushita, A., Nagai, K., Maruoka, H., Imai, Y., Beppu, M., Kawamoto, M. & Takahashi, T. (2010) Successful treatment of POEMS syndrome complicated by severe congestive heart failure with thalidomide. Internal Medicine, 49, 461-466.
41. Jaccard, A., Royer, B., Bordessoule, D., Brouet, J.C. & Fermand, J.P. (2002) High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome. Blood, 99, 3057-3059.
42. Jimenez-Zepeda, V.H., Trudel, S., Reece, D.E., Chen, C., Rabea, A.M. & Kukreti, V. (2011) Cyclophosphamide and prednisone induction followed by cyclophosphamide mobilization effectively decreases the incidence of engraftment syndrome in patients with POEMS syndrome who undergo stem cell transplantation. American Journal of Hematology, 86, 873-875.
43. Kanai, K., Kuwabara, S., Misawa, S. & Hattori, T. (2007) Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome. Internal Medicine, 46, 311-313.
44. Kanai, K., Sawai, S., Sogawa, K., Mori, M., Misawa, S., Shibuya, K., Isose, S., Fujimaki, Y., Noto, Y., Sekiguchi, Y., Nasu, S., Nakaseko, C., Takano, S., Yoshitomi, H., Miyazaki, M., Nomura, F. & Kuwabara, S. (2012) Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome. Neurology, 79, 575-582.
45. Kaygusuz, I., Tezcan, H., Cetiner, M., Kocakaya, O., Uzay, A. & Bayik, M. (2010) Bortezomib: a new therapeutic option for POEMS syndrome. European Journal of Haematology, 84, 175-177.
46. Kim, S.Y., Lee, S.A., Ryoo, H.M., Lee, K.H., Hyun, M.S. & Bae, S.H. (2006) Thalidomide for POEMS syndrome. Annals of Hematology, 85, 545-546.
47. Kulkarni, G.B., Mahadevan, A., Taly, A.B., Yasha, T.C., Seshagiri, K.S., Nalini, A., Satishchandra, P., Veerendrakumar, M. & Shankar, S.K. (2011) Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome. Journal of Clinical Neuroscience, 18, 356-360.
48. Kuwabara, S., Misawa, S., Kanai, K., Suzuki, Y., Kikkawa, Y., Sawai, S., Hattori, T., Nishimura, M. & Nakaseko, C. (2008a) Neurologic improvement after peripheral stem cell transplantation in POEMS syndrome. Neurology, 71, 1691-1695.
49. Kuwabara, S., Misawa, S., Kanai, K., Sawai, S., Hattori, T., Nishimura, M. & Nakaseko, C. (2008b) Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome. Journal of Neurology Neurosurgery & Psychiatry, 79, 1255-1257.
50. Kuwabara, S., Kanai, K., Misawa, S. & Nakaseko, C. (2009) Relapse of POEMS syndrome without increased level of VEGF. Neuromuscular Disorders, 19, 740; author reply 740-741.
51. Kuwabara, S., Dispenzieri, A., Arimura, K., Misawa, S. & Nakaseko, C. (2012) Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. Cochrane Database of Systematic Reviews, 6, CD006828.
52. Laurenti, L., De Matteis, S., Sabatelli, M., Conte, A., Chiusolo, P., Sora, F., Piccirillo, N., Za, T., Tarnani, M., Rossi, E., Leone, G. & Sica, S. (2008) Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome. Leukemia Research, 32, 1309-1312.
53. Li, J., Zhou, D.B., Huang, Z., Jiao, L., Duan, M.H., Zhang, W., Zhao, Y.Q. & Shen, T. (2011a) Clinical characteristics and long-term outcome of patients with POEMS syndrome in China. Annals of Hematology, 90, 819-826.
54. Li, J., Zhang, W., Jiao, L., Duan, M.H., Guan, H.Z., Zhu, W.G., Tian, Z. & Zhou, D.B. (2011b) Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome. Blood, 117, 6445-6449.
55. Li, J., Huang, Z., Duan, M.H., Zhang, W., Chen, M., Cao, X.X., Guan, H.Z., Tian, Z. & Zhou, D.B. (2012a) Characterization of immunoglobulin lambda light chain variable region (IGLV) gene and its relationship with clinical features in patients with POEMS syndrome. Annals of Hematology, 91, 1251-1255.
56. Li, J., Tian, Z., Zheng, H.Y., Zhang, W., Duan, M.H., Liu, Y.T., Cao, X.X. & Zhou, D.B. (2012b) Pulmonary hypertension in POEMS syndrome. Haematologica, doi:10.3324/haematol.2012.073031.
57. Li, J., Zhang, W., Duan, M.H., Jiao, L., Zhu, T.N., Han, B., Zhang, L., Gan, J. & Zhou, D.B. (2012c) PBSC mobilization in newly diagnosed patients with POEMS syndrome: outcomes and prognostic factors. Bone Marrow Transplantation, doi: 10.1038/bmt.2012.138.
58. Li, J., Zhang, W., Kang, W.Y., Cao, X.X., Duan, M.H. & Zhou, D.B. (2012d) Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome complicated by renal failure. Leukemia & Lymphoma, 53, 2527-2529.
59. Martin, S., Labauge, P., Jouanel, P., Viallard, J.L., Piette, J.C. & Sauvezie, B. (2004) Restricted use of Vlambda genes in POEMS syndrome. Haematologica, 89, ECR02.
60. Mauermann, M.L., Sorenson, E.J., Dispenzieri, A., Mandrekar, J., Suarez, G.A., Dyck, P.J. & Dyck, P.J. (2012) Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP. Journal of Neurology Neurosurgery & Psychiatry, 83, 480-486.
61. Michizono, K., Umehara, F., Hashiguchi, T., Arimura, K., Matsuura, E., Watanabe, O., Fujimoto, N., Okada, Y. & Osame, M. (2001) Circulating levels of MMP-1, -2, -3, -9, and TIMP-1 are increased in POEMS syndrome. Neurology, 56, 807-810.
62. Montoriol, P.F., Cachin, F., Michel, J.L. & Soubrier, M. (2011) Two more cases of evaluation of POEMS syndrome using 18-FDG PET/CT. European Journal of Radiology, 80, 861-864.
63. Morizane, R., Sasamura, H., Minakuchi, H., Takae, Y., Kikuchi, H., Yoshiya, N., Hashiguchi, A., Konishi, K., Okamoto, S. & Itoh, H. (2008) A case of atypical POEMS syndrome without polyneuropathy. European Journal of Haematology, 80, 452-455.
64. Nakajima, H., Ishida, S., Furutama, D., Sugino, M., Kimura, F., Yokote, T., Baba, I., Tsuji, M. & Hanafusa, T. (2007) Expression of vascular endothelial growth factor by plasma cells in the sclerotic bone lesion of a patient with POEMS syndrome. Journal of Neurology, 254, 531-533.
65. Nakanishi, T., Sobue, I., Toyokura, Y., Nishitani, H., Kuroiwa, Y., Satoyoshi, E., Tsubaki, T., Igata, A. & Ozaki, Y. (1984) The Crow-Fukase syndrome: a study of 102 cases in Japan. Neurology, 34, 712-720.
66. Narvaez, J.A., Majos, C., Narvaez, J., Valls, C. & Fernandez-Cabrera, L. (1998) POEMS syndrome: unusual radiographic, scintigraphic and CT features. European Radiology, 8, 134-136.
67. Nasu, S., Misawa, S., Sekiguchi, Y., Shibuya, K., Kanai, K., Fujimaki, Y., Ohmori, S., Mitsuma, S., Koga, S. & Kuwabara, S. (2012) Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy. Journal of Neurology Neurosurgery & Psychiatry, 83, 476-479.
68. Nobile-Orazio, E., Terenghi, F., Giannotta, C., Gallia, F. & Nozza, A. (2009) Serum VEGF levels in POEMS syndrome and in immune-mediated neuropathies. Neurology, 72, 1024-1026.
69. Ohguchi, H., Ohba, R., Onishi, Y., Fukuhara, N., Okitsu, Y., Yamamoto, J., Ishizawa, K., Ichinohasama, R. & Harigae, H. (2011) Successful treatment with bortezomib and thalidomide for POEMS syndrome. Annals of Hematology, 90, 1113-1114.
70. Ohwada, C., Nakaseko, C., Sakai, S., Takeda, Y., Abe, D., Takeuchi, M., Sakaida, E., Masuda, S., Shimizu, N., Cho, R., Nishimura, M., Kanai, K., Misawa, S. & Kuwabara, S. (2009) Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome. Bone Marrow Transplantation, 43, 739-740.
71. Patel, K., Orlowski, R.Z., Shah, N., Bashir, Q., Dinh, Y.T., Rondon, G., Giralt, S., Champlin, R. & Qazilbash, M.H. (2011) Durable responses with autologous hematopoietic stem cell transplantation in patients with POEMS syndrome. Blood (ASH Annual Meeting Abstracts), 118, abstract 4522.
72. Peggs, K.S., Paneesha, S., Kottaridis, P.D., Chakraverty, R.K., Tobias, G., Reilly, M., Mahendra, P. & Yong, K. (2002) Peripheral blood stem cell transplantation for POEMS syndrome. Bone Marrow Transplantation, 30, 401-404.
73. Rose, C., Zandecki, M., Copin, M.C., Gosset, P., Labalette, M., Hatron, P.Y., Jauberteau, M.O., Devulder, B., Bauters, F. & Facon, T. (1997) POEMS syndrome: report on six patients with unusual clinical signs, elevated levels of cytokines, macrophage involvement and chromosomal aberrations of bone marrow plasma cells. Leukemia, 11, 1318-1323.
74. Samaras, P., Bauer, S., Stenner-Liewen, F., Steiner, R., Zweifel, M., Renner, C. & Knuth, A. (2007) Treatment of POEMS syndrome with bevacizumab. Haematologica, 92, 1438-1439.
75. Scarlato, M., Previtali, S.C., Carpo, M., Pareyson, D., Briani, C., Del, B.R., Nobile-Orazio, E., Quattrini, A. & Comi, G.P. (2005) Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain, 128, 1911-1920.
76. Sethi, S., Tageja, N., Arabi, H. & Penumetcha, R. (2009) Lenalidomide therapy in a rare case of POEMS syndrome with kappa restriction. Southern Medical Journal, 102, 1092-1093.
77. Shibuya, K., Misawa, S., Horikoshi, T., Kanai, K., Isose, S., Nasu, S., Sekiguchi, Y., Noto, Y., Fujimaki, Y., Nakaseko, C. & Kuwabara, S. (2011) Detection of bone lesions by CT in POEMS syndrome. Internal Medicine, 50, 1393-1396.
78. Shimizu, N., Nakaseko, C., Sakaida, E., Ohwada, C., Takeuchi, M., Kawaguchi, T., Tsukamoto, S., Sakai, S., Takeda, Y., Abe, D., Yokote, K., Iseki, T., Kanai, K., Misawa, S. & Kuwabara, S. (2012a) Factors associated with the efficiency of PBSC collection in POEMS syndrome patients undergoing autologous PBSC transplantation. Bone Marrow Transplantation, 47, 1010-1012.
79. Shimizu, N., Sakaida, E., Ohwada, C., Takeuchi, M., Kawaguchi, T., Tsukamoto, S., Sakai, S., Takeda, Y., Sugita, Y., Yokote, K., Iseki, T., Isose, S., Kanai, K., Misawa, S., Kuwabara, S. & Nakaseko, C. (2012b) Mobilization of PBSCs in poor mobilizers with POEMS syndrome using G-CSF with plerixafor. Bone Marrow Transplantation, 47, 1587-1588.
80. Sinisalo, M., Hietaharju, A., Sauranen, J. & Wirta, O. (2004) Thalidomide in POEMS syndrome: case report. American Journal of Hematology, 76, 66-68.
81. Sobas, M.A., Alonso, V.N., Diaz, A.J., Bendana, L.A., Fraga, R.M. & Bello, L.J.L. (2010) Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant). Annals of Hematology, 89, 217-219.
82. Soubrier, M.J., Dubost, J.J. & Sauvezie, B.J. (1994) POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome. American Journal of Medicine, 97, 543-553.
83. Soubrier, M., Dubost, J.J., Serre, A.F., Ristori, J.M., Sauvezie, B., Cathebras, P., Piette, J.C., Chapman, A., Authier, F.J. & Gherardi, R.K. (1997) Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis & Rheumatism, 40, 786-787.
84. Stankowski-Drengler, T., Gertz, M.A., Katzmann, J.A., Lacy, M.Q., Kumar, S., Leung, N., Hayman, S.R., Buadi, F., Kyle, R.A., Rajkumar, S.V. & Dispenzieri, A. (2010) Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome. American Journal of Hematology, 85, 431-434.
85. Stefanelli, A., Treglia, G., Leccisotti, L., Laurenti, L., Luigetti, M., Sabatelli, M. & Giordano, A. (2012) Usefulness of F-18 FDG PET/CT in the follow-up of POEMS syndrome after autologous peripheral blood stem cell transplantation. Clinical Nuclear Medicine, 37, 181-183.
86. Straume, O., Bergheim, J. & Ernst, P. (2006) Bevacizumab therapy for POEMS syndrome. Blood, 107, 4972-4973; author reply 4973-4974.
87. Suyani, E., Yagci, M. & Sucak, G.T. (2011) Complete remission with a combination of lenalidomide, cyclophosphamide and prednisolone in a patient with incomplete POEMS syndrome. Acta Haematologica, 126, 199-201.
88. Tang, X., Shi, X., Sun, A., Qiu, H., Gu, B., Zhou, H., Xue, S., Liu, Y., Ruan, C. & Wu, D. (2009) Successful bortezomib-based treatment in POEMS syndrome. European Journal of Haematology, 83, 609-610.
89. Thoennissen, G.B., Thoennissen, N.H., Fritz, F., Hilbig, A., Kerkhoff, A., Liersch, R., Krug, U., Koschmieder, S., Muller-Tidow, C., Mesters, R., Kropff, M. & Berdel, W.E. (2012) POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience. Annals of Hematology, 91, 1419-1425.
90. Tomas, J.F., Giraldo, P., Lecumberri, R. & Nistal, S. (2012) POEMS syndrome with severe neurological damage clinically recovered with lenalidomide. Haematologica, 97, 320-322.
91. Vannata, B., Laurenti, L., Chiusolo, P., Sora, F., Balducci, M., Sabatelli, M., Luigetti, M., Giannotta, C., De Stefano, V., Leone, G. & Sica, S. (2012) Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation. American Journal of Hematology, 87, 641-642.
92. Vital, C., Vital, A., Ferrer, X., Viallard, J.F., Pellegrin, J.L., Bouillot, S., Larrieu, J.M., Lequen, L., Larrieu, J.L., Brechenmacher, C., Petry, K.G. & Lagueny, A. (2003) Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases. Journal of the Peripheral Nervous System, 8, 136-144.
93. Wang, X., Ye, S., Xiong, C., Gao, J., Xiao, C. & Xing, X. (2011) Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease. Japanese Journal of Clinical Oncology, 41, 1221-1224.
94. Warsame, R., Kohut, I.E. & Dispenzieri, A. (2012) Successful use of cyclophosphamide, bortezomib, and dexamethasone to treat a case of relapsed POEMS. European Journal of Haematology, 88, 549-550.
95. Watanabe, O., Arimura, K., Kitajima, I., Osame, M. & Maruyama, I. (1996) Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet, 347, 702.
96. Watanabe, O., Maruyama, I., Arimura, K., Kitajima, I., Arimura, H., Hanatani, M., Matsuo, K., Arisato, T. & Osame, M. (1998) Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle and Nerve, 21, 1390-1397.
97. Yamada, Y., Sawai, S., Misawa, S., Kanai, K., Shibuya, K., Mori, M., Moriya, J., Sogawa, K., Yamamoto, H., Beppu, M., Taniguchi, J., Nakaseko, C., Nomura, F. & Kuwabara, S. (2013) Multiple angiogenetic factors are upregulated in POEMS syndrome. Annals of Hematology, 92, 245-248.